trial

Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia

NCTId NCT01465074
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 20 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2013-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
20 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2011-11
Primary completion
2013-04
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Nicotine polacrilexRegular chewing gum; Dentyne Ice, Wrigely´s Mint Gum

Sponsors

Centre for Addiction and Mental HealthLead Sponsor

Investigators

2
Tony P George, M.D.Principal Investigator
Jeff Z Daskalakis, M.D., Ph.D.Principal Investigator

Sites

1 total
Toronto, Canada

Facts & assertions

4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2013-04
Status
TERMINATED
relationships
The graph out of here
drug
Nicotine polacrilex
drug
Regular chewing gum; Dentyne Ice, Wrigely´s Mint Gum
drug
lead_sponsor
Centre for Addiction and Mental Health
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Tony P George, M.D.
person
Jeff Z Daskalakis, M.D., Ph.D.
person